Research into hybrid IDs is a rapidly evolving field. Advances in genetic technologies, such as CRISPR and gene therapy, hold promise for future treatments. Ongoing studies aim to better understand the complex interactions between different genetic mutations and their clinical manifestations. Collaborative efforts between researchers, clinicians, and families are essential to drive progress in this field.
